Fund: ISHNASDE
| iShares Nasdaq US Biotechnology UCITS ETF EUR | |
| IE00BYXG2H39 | |
| 19-10-2017 | |
| Equity | |
| Equity Sectors - Health Care | |
| BlackRock iShares | |
| BlackRock Advisors (UK) Limited | |
| EUR | |
| 100 | |
| 5% |
| 1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Výkonnosť fondu | -6.35% | -6.63% | 6.85% | 3.35% | 1.67% | -2.06% | 5.10% | - | - | N/A | |
| Priemerná výkonnosť (36 meraní) | 0.22% | 1.51% | 6.89% | - | - | ||||||
| Volatilita od priemernej výkonnosti | 7.74% | 19.46% | 8.55% | - | - |
| Long | Short | Net | |
|---|---|---|---|
| Stock | 99.83% | 99.83% | |
| Bond | 0.00% | 0.00% | |
| Other | |||
| Cash | 0.18% | 0.01% | 0.17% |
| Aktíva | 4,777 mil. |
| Počet akcíí | 218 |
| Počet dlhopisov | 0 |
| Priebež. popl. | 0.35 |
| z toho Mng. popl. | 0.35 |
| Výk. prémia | |
| Trans. popl. |
| Dividenda | |
| Dividendový výnos | |
| Rozhodný dátum | |
| Frekvencia výplaty |
| Giant | 5.87% |
| Large | 34.56% |
| Medium | 26.36% |
| Small | 18.24% |
| Micro | 13.04% |
| P/E | 15.37% |
| P/BV | 3.19% |
| Healthcare | 99.83% |
| Government | 0.00 |
| Corporate | 0.00 |
| Derivatives | 0.17 |
| Výnos do splatnosti p.a. | |
| Modifikovaná durácia |
| AAA | 0.00 |
| AA | 2.59 |
| A | 0.00 |
| BBB | 0.00 |
| BB | 0.00 |
| B | 0.00 |
| Below B | 0.00 |
| Not Rated | 97.41 |
| United States | 87.81% |
| Canada | 0.65% |
| Latin America | |
| United Kingdom | 5.99% |
| Eurozone | 3.01% |
| Europe - ex Euro | 1.57% |
| Europe - Emerging | |
| Africa | |
| Middle East | |
| Japan | |
| Australasia | |
| Asia - Developed | 0.12% |
| Asia - Emerging | 0.68% |
| Emerging Market | 0.68% |
| Developed Country | 99.15% |
| Not Classified |
| Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
|---|---|---|---|---|---|
| Amgen Inc | Healthcare | 8.43% | Vertex Pharmaceuticals Inc | Healthcare | 8.17% |
| Regeneron Pharmaceuticals Inc | Healthcare | 8.16% | Gilead Sciences Inc | Healthcare | 8.12% |
| AstraZeneca PLC ADR | Healthcare | 4.46% | Moderna Inc | Healthcare | 4.41% |
| Biogen Inc | Healthcare | 3.12% | Illumina Inc | Healthcare | 2.1% |
| Alnylam Pharmaceuticals Inc | Healthcare | 2.04% | Biomarin Pharmaceutical Inc | Healthcare | 1.91% |